Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Grinblatt · SciRah

Researcher profile · Semantic Scholar

D. Grinblatt

Share profile

D. Grinblatt — researcher profile on SciRah

h-index: 16
Works: 113
Citations: 714

Most-cited papers

Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially?
J. Mehta, L. I. Gordon, M. Tallman, J. N. Winter +7 more
2006Bone Marrow Transplantation56 citations
Semantic Scholar
Real‐world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres
A. Mato, C. Nabhan, Neil E. Kay, M. Weiss +12 more
2016British Journal of Haematology45 citations Open access
Semantic Scholar
Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the AVIDA® registry
D. Grinblatt, M. Sekeres, R. Komrokji, A. Swern +2 more
2015Leukemia and Lymphoma39 citations
Semantic Scholar
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia
C. Pashos, C. Flowers, N. Kay, M. Weiss +12 more
2013Supportive Care in Cancer37 citations
Semantic Scholar
Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation
J. Mehta, O. Frankfurt, J. Altman, A. Evens +11 more
2009Leukemia and Lymphoma34 citations
Semantic Scholar
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study.
B. Derman, A. Kansagra, J. Zonder, A. Stefka +11 more
2022JAMA Oncology33 citations Open access
Semantic Scholar
Azacitidine in Lower-Risk Myelodysplastic Syndromes: A Meta-Analysis of Data from Prospective Studies.
R. Komrokji, A. Swern, D. Grinblatt, R. Lyons +7 more
2018The Oncologist33 citations Open access
Semantic Scholar
Thalidomide has limited single‐agent activity in relapsed or refractory indolent non‐Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B
Sonali M. Smith, D. Grinblatt, Jeffrey L. Johnson, D. Niedzwiecki +3 more
2008British Journal of Haematology31 citations
Semantic Scholar
Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study
C. Klein, H. Kastrissios, Antonius A. Miller, D. Hollis +5 more
2005Cancer Chemotherapy and Pharmacology31 citations
Semantic Scholar
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real‐world Clinical Experience in the Connect CLL Registry
A. Mato, C. Nabhan, N. Kay, N. Lamanna +11 more
2017Clinical Lymphoma, Myeloma & Leukemia28 citations Open access
Semantic Scholar
The Connect CLL Registry: final analysis of 1494 patients with chronic lymphocytic leukemia across 199 US sites.
A. Mato, C. Nabhan, N. Lamanna, Neil E. Kay +11 more
2020Blood Advances19 citations Open access
Semantic Scholar
A Study Comparing Dosing Regimens and Efficacy of Subcutaneous to Intravenous Azacitidine (AZA) for the Treatment of Myelodysplastic Syndromes (MDS).
M. Sekeres, J. Maciejewski, D. Donley, D. Grinblatt +7 more
200917 citations
Semantic Scholar
Early progression of disease as a predictor of survival in chronic lymphocytic leukemia.
Inhye E. Ahn, C. Farber, M. Davids, D. Grinblatt +10 more
2017Blood Advances16 citations Open access
Semantic Scholar
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation
S. Singhal, L. I. Gordon, M. Tallman, J. N. Winter +7 more
2006Bone Marrow Transplantation14 citations
Semantic Scholar
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study
D. Steensma, M. Abedi, R. Bejar, C. Cogle +16 more
2016BMC Cancer13 citations Open access
Semantic Scholar
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas
X. Poiré, J. Kline, D. Grinblatt, T. Zimmerman +5 more
2010Leukemia and Lymphoma13 citations
Semantic Scholar
Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States
C. Nabhan, A. Mato, C. Flowers, D. Grinblatt +9 more
2017BMC Cancer12 citations Open access
Semantic Scholar
A Case of Severe, Nilotinib-Induced Liver Injury
Yuliya Belopolsky, D. Grinblatt, H. M. Dunnenberger, L. Sabatini +2 more
2019ACG Case Reports Journal11 citations Open access
Semantic Scholar
Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
L. Zeidman, Christopher D. Fahey, D. Grinblatt, Krisztina Harsanyi
2006Pediatric Neurology11 citations
Semantic Scholar
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry
D. Pollyea, T. George, M. Abedi, R. Bejar +20 more
2020eJHaem10 citations Open access
Semantic Scholar
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
B. Tomlinson, M. D. De Lima, C. Cogle, M. Thompson +21 more
2023Transplantation and Cellular Therapy9 citations Open access
Semantic Scholar
Treatment of Patients with Low-Risk Myelodysplastic Syndromes Receiving Azacitidine Who Are Enrolled in AVIDA, a Longitudinal Patient Registry.
D. Grinblatt, M. Narang, J. Malone, David A. Sweet +2 more
20087 citations
Semantic Scholar
Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation
S. Singhal, L. I. Gordon, M. Tallman, J. N. Winter +7 more
2006Bone Marrow Transplantation7 citations Open access
Semantic Scholar
Therapeutic Response to Azacitidine (AZA) In Patients with Secondary Myelodysplastic Syndromes (sMDS) Enrolled In the AVIDA Registry
M. Sekeres, M. Narang, R. Komrokji, J. Maciejewski +5 more
20106 citations
Semantic Scholar
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes
Jay L. Patel, M. Abedi, C. Cogle, H. Erba +20 more
2020International Journal of Laboratory Hematology5 citations Open access
Semantic Scholar
Early Peripheral Blood Minimal Residual Disease Status By NGS in Patients with Newly Diagnosed Multiple Myeloma (MM) on a Phase 2 Trial Receiving Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd)
B. Derman, T. Kubicki, H. Simmons, Aimaz Afrough +13 more
2023Blood4 citations Open access
Semantic Scholar
Interim analysis of a phase 2 minimal residual disease (MRD)-adaptive trial of elotuzumab, carfilzomib, lenalidomide, and dexamethasone (Elo-KRd) for newly diagnosed multiple myeloma (MM).
B. Derman, J. Zonder, A. Kansagra, D. Grinblatt +16 more
20214 citations
Semantic Scholar
Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry
J. Sharman, K. Cocks, C. Nabhan, N. Lamanna +11 more
2020eJHaem4 citations Open access
Semantic Scholar
Patterns of Care for Patients with Chronic Lymphocytic Leukemia (CLL): The Connect ® CLL Disease Registry
J. Sharman, C. Flowers, M. Weiss, D. Grinblatt +12 more
20114 citations
Semantic Scholar
Treatment Patterns and Outcomes of Patients with Acute Myeloid Leukemia (AML) from 2013 to 2022: A Connect ® Myeloid Registry Study
D. Grinblatt, G. Roboz, D. Pollyea, M. Sekeres +15 more
2023Blood3 citations Open access
Semantic Scholar
Treatment Patterns and Outcomes of Patients with Lower-Risk Myelodysplastic Syndromes in the Connect ® Myeloid Disease Registry
R. Komrokji, T. George, H. Erba, B. Scott +10 more
2021Blood3 citations Open access
Semantic Scholar
Trastuzumab-Induced Thrombocytopenia Correlated by Drug-Dependent Platelet Antibodies.
K. Sullivan, L. Kaminer, D. Grinblatt, N. Campbell +6 more
2020JCO Oncology Practice3 citations
Semantic Scholar
Current Diagnosis Patterns for Acute Myeloid Leukemia (AML) in Clinical Practice Compared with World Health Organization (WHO) 2008 Recommendations: Outcomes from the CONNECT® Myelodysplastic Syndromes (MDS) and AML Disease Registry
T. George, H. Erba, D. Steensma, D. Pollyea +19 more
20163 citations Open access
Semantic Scholar
Demographics By Age Group (AG) and Line of Therapy (LOT) in Chronic Lymphocytic Leukemia (CLL) Patients (Pts) Treated in US Practices from the Connect® CLL Registry
J. Sharman, A. Mato, N. Kay, T. Kipps +11 more
20143 citations
Semantic Scholar
Variation in health-related quality of life (HRQOL) by ECOG performance status (PS) and fatigue among patients with chronic lymphocytic leukemia (CLL).
C. Flowers, C. Pashos, M. Weiss, N. Lamanna +14 more
20123 citations
Semantic Scholar
Streamline: Retrospective Cohort Study of FMS-Like Tyrosine Kinase 3-Mutated Acute Myeloid Leukemia – Real-World Treatment Patterns and Clinical Outcomes of Patients in First Relapse or Refractory Diagnosis
A. Zeidan, Rebekah Yu, Yue-Xi Wang, Zi-Yu Lan +7 more
2025Acta Haematologica2 citations Open access
Semantic Scholar
Transplant Referral Patterns for Patients (Pts) with Newly Diagnosed (ND) Higher-Risk (HR) Myelodysplastic Syndromes (MDS), and European Leukemianet (ELN) 2010 Intermediate-Risk (IR) or Adverse-Risk (AR) Acute Myeloid Leukemia (AML) in the Connect® MDS/AML Registry
B. Tomlinson, M. D. De Lima, C. Cogle, M. Thompson +14 more
2020Biology of Blood and Marrow Transplantation2 citations Open access
Semantic Scholar
Ironclad: A randomized phase III study of ibrutinib (Ibr) or no consolidation following autologous hematopoietic stem cell transplantation (AutoHCT) for relapsed/refractory activated-B-cell (ABC) subtype diffuse large B-cell lymphoma (DLBCL).
C. Andreadis, T. Fenske, B. Hill, P. Stiff +16 more
20172 citations
Semantic Scholar
Prognostic testing patterns in CLL pts treated in U.S. practices from the Connect CLL registry.
A. Mato, C. Flowers, C. Farber, M. Weiss +12 more
20152 citations
Semantic Scholar
Variation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia
N. Kay, C. Flowers, M. Weiss, N. Lamanna +12 more
20122 citations
Semantic Scholar
155 Health-related quality of life by RBC transfusion dependence (TD) or independence (TI) of patients (Pts) initiating treatment for MDS
C. Pashos, D. Grinblatt, M. Sekeres, R. Komrokji +5 more
20112 citations
Semantic Scholar
Association of Changes in Transfusion Status with Changes in Health-Related Quality of Life of Real-World Patients with MDS Across Six Months of Treatment with Azacitidine
C. Pashos, D. Grinblatt, M. Sekeres, R. Komrokji +6 more
20112 citations
Semantic Scholar
The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research
E. Flick, H. Terebelo, S. Fish, Amani Kitali +6 more
2023The Oncologist1 citations Open access
Semantic Scholar
Epstein–Barr Virus Driven Hodgkin's Lymphoma after a Short Course of Daratumumab Treatment for Relapsed Multiple Myeloma
Moeen Mohammadi-Oroujeh, A. Mehreen, D. Grinblatt
2023Case Reports in Hematology1 citations Open access
Semantic Scholar
Real-World Use of FLT3-TKIs in R/R FLT3-Mutated AML in the United States
D. Grinblatt, B. Pandya, Wei Han, Loretta Sullivan +2 more
20201 citations
Semantic Scholar
Streamline - Study of Relapse or Refractory (R/R) FLT3-Mutated Acute Myeloid Leukemia (AML) Using Electronic Medical Records (EMR): First Analysis from a Multicenter, Retrospective Cohort Study
A. Zeidan, A. Gilligan, S. Gautam, N. Hu +2 more
2019Blood1 citations Open access
Semantic Scholar
Factors Associated with Early Therapy Initiation in Patients (pts) with Myelodysplastic Syndromes (MDS) in the Connect® MDS/AML Disease Registry
C. Cogle, G. Garcia-Manero, D. Grinblatt, R. Komrokji +9 more
2018Blood1 citations Open access
Semantic Scholar
Early Progression of Disease (< 2 Years) Is a Negative Predictor of Survival in Patients (Pts) with Chronic Lymphocytic Leukemia (CLL): An Analysis from the Connect® CLL Registry
Inhye E. Ahn, C. Farber, M. Davids, D. Grinblatt +10 more
20161 citations
Semantic Scholar
PCN103 Variation in Health-Related Quality of Life by Age Among Patients With Chronic Lymphocytic Leukemia
C. Pashos, C. Flowers, M. Weiss, N. Lamanna +14 more
20121 citations Open access
Semantic Scholar
Variation in Health-Related Quality of Life by ECOG Performance Status and Fatigue Among Patients with Chronic Lymphocytic Leukemia
C. Pashos, C. Flowers, M. Weiss, N. Lamanna +14 more
20111 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Swern×25
Invite
A. Swern — researcher profile on SciRah
Kristen A. Sullivan×21
Invite
Kristen A. Sullivan — researcher profile on SciRah
P. Kiselev×16
Invite
P. Kiselev — researcher profile on SciRah
N. Lamanna×15
Invite
N. Lamanna — researcher profile on SciRah

×15

Invite

R. Komrokji — researcher profile on SciRah

Invite

E. Flick — researcher profile on SciRah

Invite

J. Sharman — researcher profile on SciRah

Invite

M. Sekeres — researcher profile on SciRah

Invite

C. Flowers — researcher profile on SciRah

Invite

C. Farber — researcher profile on SciRah

Thomas K. Street×10

Invite

Thomas K. Street — researcher profile on SciRah

Invite

A. Mato — researcher profile on SciRah